Literature DB >> 33446204

Proliferation ability of particulated juvenile allograft cartilage.

Changgui Zhang1, Xingyu Zhao1, Yunong Ao1, Jin Cao1, Liu Yang1, Xiaojun Duan2.   

Abstract

BACKGROUND: Particulated juvenile allograft cartilage (PJAC) has a good short-term clinical efficacy in repairing articular cartilage defects, but the proliferation ability of PJAC and the biological characteristics of transplanted cells after transplantation are still unclear.
PURPOSE: To study the cartilage proliferation ability of PJAC in repairing full-thickness cartilage defects and the reasons for proliferation to provide experimental evidence for its clinical application. STUDY
DESIGN: Controlled laboratory study.
METHODS: Twenty Guizhou minipigs were randomly divided into the experimental group and control group. In all minipigs, an 8-mm cylindrical full-thickness cartilage defect was created in the femoral trochlea of one knee. The experimental group received PJAC transplantation from five juvenile donors of Guizhou minipigs (PJAC group; n = 10) and the control group received transplantation of autologous cartilage chips (ACC group; n = 10). Both groups were followed at 1 and 3 months after surgery, immunohistochemical evaluation of the tissue sections Ki-67 and Lin28 was conducted, the positive rate was calculated according to the staining, and the proliferation ability of PJAC was analyzed.
RESULTS: All 20 Guizhou minipigs were followed, and there was no infection or incision healing disorder after surgery. By Ki-67 and Lin28 immunohistochemical tests, the positive rate of Ki-67 was 88.9 ± 0.2% in the PJAC group and 28.3 ± 3.6% in the ACC group at 1 month, and the difference was statistically significant (P < 0.05); the positive rate of Lin28 was 34.6 ± 3.3% in the PJAC group and 7.6 ± 1.4% in the ACC group at 1 month, and the difference was statistically significant (P < 0.05). At 3 months, the positive rates of Ki-67 in the PJAC group and ACC group were 53.6 ± 6.9% and 1.97 ± 0.3%, respectively (P < 0.05); the positive rates of Lin28 were 86.6 ± 3.3% and 1.4 ± 0.3%, respectively (P < 0.01).
CONCLUSION: A large animal model was established with Guizhou minipigs, and the expressions of Ki-67 protein and Lin28 protein detected by immunohistochemistry in the repaired transplanted tissue of the PJAC group were stronger than those of adult cartilage. The proliferation of PJAC within 3 months of transplantation was stronger than that of adult cartilage. The enhanced expression of Lin28 may be one of the mechanisms by which PJAC achieved stronger proliferation ability than adult cartilage. PJAC technology has shown good application prospects for repairing cartilage defects.

Entities:  

Keywords:  Autologous cartilage chip transplantation; Donor cells; Ki-67; Lin28; Particulated juvenile allograft cartilage; Proliferation

Mesh:

Substances:

Year:  2021        PMID: 33446204      PMCID: PMC7809761          DOI: 10.1186/s13018-020-02199-z

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  30 in total

1.  Neonatal rat cartilage has the capacity for tissue regeneration.

Authors:  W Wagner; J Reichl; M Wehrmann; H P Zenner
Journal:  Wound Repair Regen       Date:  2001 Nov-Dec       Impact factor: 3.617

2.  Spontaneous repair of superficial defects in articular cartilage in a fetal lamb model.

Authors:  R S Namba; M Meuli; K M Sullivan; A X Le; N S Adzick
Journal:  J Bone Joint Surg Am       Date:  1998-01       Impact factor: 5.284

3.  Expressions of membrane-type I matrix metalloproteinase, Ki-67 protein, and type II collagen by chondrocytes migrating from cartilage endplate into nucleus pulposus in rat intervertebral discs: a cartilage endplate-fracture model using an intervertebral disc organ culture.

Authors:  Ki-Won Kim; Kee-Yong Ha; Jong-Beom Park; Young-Kyun Woo; Ha-Na Chung; Howard S An
Journal:  Spine (Phila Pa 1976)       Date:  2005-06-15       Impact factor: 3.468

Review 4.  The response of articular cartilage to mechanical injury.

Authors:  H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1982-03       Impact factor: 5.284

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  Cocultures of adult and juvenile chondrocytes compared with adult and juvenile chondral fragments: in vitro matrix production.

Authors:  Davide Edoardo Bonasia; James A Martin; Antongiulio Marmotti; Richard L Amendola; Joseph A Buckwalter; Roberto Rossi; Davide Blonna; Huston Davis Adkisson; Annunziato Amendola
Journal:  Am J Sports Med       Date:  2011-08-09       Impact factor: 6.202

7.  Immunohistochemical analysis of Ki-67, p21waf1/cip1 and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial.

Authors:  R D Bonfil; A D Gonzalez; D Siguelboim; F D Cuello Carrion; D R Ciocca; A Villaronga; L Metz; F Mosso; E Fayad; M Reale; A J Schmilovich
Journal:  BJU Int       Date:  2001-09       Impact factor: 5.588

Review 8.  Animal models for cartilage regeneration and repair.

Authors:  Constance R Chu; Michal Szczodry; Stephen Bruno
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

9.  Intra-uterine healing of fetal rat oral mucosal, skin and cartilage wounds.

Authors:  A N Goss
Journal:  J Oral Pathol       Date:  1977-01

10.  Lin28 enhances tissue repair by reprogramming cellular metabolism.

Authors:  Ng Shyh-Chang; Hao Zhu; T Yvanka de Soysa; Gen Shinoda; Marc T Seligson; Kaloyan M Tsanov; Liem Nguyen; John M Asara; Lewis C Cantley; George Q Daley
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

View more
  1 in total

Review 1.  Insights into the present and future of cartilage regeneration and joint repair.

Authors:  H Evenbratt; L Andreasson; V Bicknell; M Brittberg; R Mobini; S Simonsson
Journal:  Cell Regen       Date:  2022-02-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.